Global Medical Science Leader Alzheimer’s Disease

Lead and coordinate medical strategy contributions to the integrated product life-cycle strategy for assigned products within the disease area. Develop and execute evidence generation strategies that incorporate "essential clinical practice data" and address "access" needs. Coordinate the overall integrated evidence strategy, encompassing Clinical Development Plans (CDP) and data needs for market access and value demonstration. Collaborate closely with cross-functional partners in Scientific Communication, Patient Partnership, Commercial, and Research & Drug Development. Represent medical expertise in clinical research and clinical practice to catalyze the transformation of the respective disease area. Maintain a current view of external trends, stakeholder expectations, and healthcare ecosystem needs. Integrate perspectives from multiple stakeholders, including HCPs, patients, nurses, and payers, into strategic decision-making.

At Roche, we are expanding our global medical affairs team in Neurology, specifically Alzheimer’s disease (AD) with one opening for a Global Medical Science Leader (GMSL). The Alzheimer’s Medical team is dedicated to understanding, anticipating, and contributing to the transformation of clinical practice. You will join a highly collaborative, matrixed environment where scientific expertise meets strategic planning to improve patient outcomes in healthcare ecosystems worldwide. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are, allowing you to thrive both personally and professionally.

• An MD with relevant clinical research and practice experience, including patient care decision-making

• Specialization degree (neurology board certification) and experience in Alzheimer’s disease (fellowship or similar)

• Proven ability to work effectively in a matrix environment with diverse cross-functional colleagues

• Strong understanding of the Integrated Development and Commercialization Planning process

• Expertise in evidence generation and the ability to translate complex medical data into actionable strategy